40 years after the registration of acyclovir: do we need new anti-herpetic drugs?
A Majewska, B Mlynarczyk-Bonikowska - International journal of …, 2022 - mdpi.com
Herpes simplex virus types 1 and 2 HSV1 and 2, namely varicella-zoster VZV and
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …
cytomegalovirus CMV, are among the most common pathogens worldwide. They remain in …
Virus-like particles and nanoparticles for vaccine development against HCMV
M Perotti, L Perez - Viruses, 2019 - mdpi.com
Human cytomegalovirus (HCMV) infects more than 70% of the human population worldwide.
HCMV is responsible for high morbidity and mortality in immunocompromised patients and …
HCMV is responsible for high morbidity and mortality in immunocompromised patients and …
[HTML][HTML] Vaccine value profile for cytomegalovirus
Cytomegalovirus (CMV) is the most common infectious cause of congenital malformation
and a leading cause of developmental disabilities such as sensorineural hearing loss …
and a leading cause of developmental disabilities such as sensorineural hearing loss …
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread
AC Gomes, IA Baraniak, A Lankina, Z Moulder… - Nature …, 2023 - nature.com
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A
recombinant form of a protein essential for CMV entry, glycoprotein B (gB), demonstrated …
recombinant form of a protein essential for CMV entry, glycoprotein B (gB), demonstrated …
Myocarditis: causes, mechanisms, and evolving therapies
T Kyaw, G Drummond, A Bobik… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction Myocarditis is a severe lymphocyte-mediated inflammatory disorder of the heart,
mostly caused by viruses and immune checkpoint inhibitors (ICIs). Recently, myocarditis as …
mostly caused by viruses and immune checkpoint inhibitors (ICIs). Recently, myocarditis as …
[HTML][HTML] Insight for immunotherapy of HCMV infection
X Long, Y Qiu, Z Zhang, M Wu - International journal of biological …, 2021 - ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV), a ubiquitous in humans, has a high prevalence rate.
Young people are susceptible to HCMV infection in develo** countries, while older …
Young people are susceptible to HCMV infection in develo** countries, while older …
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
SJ Theobald, C Kreer, S Khailaie, A Bonifacius… - PLoS …, 2020 - journals.plos.org
Human cytomegalovirus (HCMV) causes serious complications to immune compromised
hosts. Dendritic cells (iDCgB) expressing granulocyte-macrophage colony-stimulating factor …
hosts. Dendritic cells (iDCgB) expressing granulocyte-macrophage colony-stimulating factor …
Common polymorphisms in the glycoproteins of human cytomegalovirus and associated strain-specific immunity
Human cytomegalovirus (HCMV), one of the most prevalent viruses across the globe, is a
common cause of morbidity and mortality for immunocompromised individuals. Recent …
common cause of morbidity and mortality for immunocompromised individuals. Recent …
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice
There is now convincing evidence that the successful development of an effective CMV
vaccine will require improved formulation and adjuvant selection that is capable of inducing …
vaccine will require improved formulation and adjuvant selection that is capable of inducing …
Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity
M Perotti, J Marcandalli, D Demurtas, F Sallusto… - PLoS …, 2020 - journals.plos.org
Human cytomegalovirus (HCMV) is the primary viral cause of congenital birth defects and
causes significant morbidity and mortality in immune-suppressed transplant recipients …
causes significant morbidity and mortality in immune-suppressed transplant recipients …